Pharmaceutical and clinical development of a novel progesterone formulation

E-ISSN： 1600-0412|94|S161|28-37

ISSN： 0001-6349

Source： ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, Vol.94, Iss.S161, 2015-11, pp. : 28-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review of the pharmaceutical properties and clinical effects of the topical NSAID formulation, diclofenac epolamine

By Rainsford K. D. Kean W. F. Ehrlich G. E.

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2967-2992

Informa Healthcare

Access to resources Recommend Favorite

Seborrhoeic keratosis removal in a multicentre phase I/II clinical trial using a novel topical formulation (BL‐5010)

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 1, 2015-07 ,pp. : 247-249

John Wiley & Sons Inc

Access to resources Recommend Favorite

The potential role for cladribine in the treatment of multiple sclerosis: clinical experience and development of an oral tablet formulation

By Leist Thomas P. Vermersch Patrick

Current Medical Research and Opinion, Vol. 23, Iss. 11, 2007-11 ,pp. : 2667-2676

Informa Healthcare

Access to resources Recommend Favorite

Pre‐clinical formulation screening, development and stability of acetyl aspartic acid for cosmetic application

INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, Vol. 37, Iss. S1, 2015-10 ,pp. : 28-33

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent

By Amadori S. Fenaux P. Ludwig H. O'Dwyer M. Sanz M.

Current Medical Research and Opinion, Vol. 21, Iss. 3, 2005-03 ,pp. : 403-412

Informa Healthcare

Access to resources Recommend Favorite